Notes / Company

Piramal Pharma Ltd.

PPLPHARMA BSE 543635 ISIN INE0DK501011 CDMO

Fundamentals

Market cap: ₹22,325 cr
ROE: 1.12%
Debt / equity: 0.58
52-week range: 132.30 — 220.85

Research on Tijori Finance

Company snapshot

Piramal Pharma Ltd.

CDMO

₹22,187 cr

Latest quarter · Mar 2026

Sales₹2,752 cr

Net profit−₹22 cr

Op. margin+16.7%

EPS−₹0.07

Strength & growth

Debt / equity0.58×

Current ratio1.54×

The timeline — 1 note on Piramal Pharma Ltd.

June 2026

03 Jun 26 · 11:02 AM IST Brief

Brief · Regulatory · Large cap

Piramal Pharma's Dahej plant clears its last environmental hurdle

The Gujarat Pollution Control Board has permanently revoked its closure directions. The risk of a surprise shutdown at a key manufacturing hub is gone.

Verify on exchange BSE filings for PPLPHARMA NSE filings for PPLPHARMA Tijori Finance company page